DHG Pharmaceutical JSC
DHG Pharmaceutical Joint Stock Company, together with its subsidiaries, engages in the manufacture and sale of pharmaceutical products in Vietnam. The company offers antibiotic, analgesic and antipyretic, respiratory, nutrition, musculoskeletal, gastrointestinal and hepatobiliary, nervous and ophthalmic, cardiovascular and diabetic, and dermatology and beauty care products. It also manufactures a… Read more
DHG Pharmaceutical JSC (DHG) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2025: 0.107x
Based on the latest financial reports, DHG Pharmaceutical JSC (DHG) has a cash flow conversion efficiency ratio of 0.107x as of December 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₫447.50 Billion) by net assets (₫4.18 Trillion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
DHG Pharmaceutical JSC - Cash Flow Conversion Efficiency Trend (2019–2025)
This chart illustrates how DHG Pharmaceutical JSC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
DHG Pharmaceutical JSC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of DHG Pharmaceutical JSC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Home Federal Bancorp Louisiana
NASDAQ:HFBL
|
0.056x |
|
Ganesh Benzoplast Limited
NSE:GANESHBE
|
0.017x |
|
Scilex Holding Company
NASDAQ:SCLX
|
-0.046x |
|
Siam Pan Group PCL
BK:SPG
|
0.014x |
|
Indo Tech Transformers Limited
NSE:INDOTECH
|
0.000x |
|
Chi Hua Fitness Co Ltd
TWO:1593
|
0.029x |
|
BMT Co. Ltd
KQ:086670
|
0.034x |
|
Samsung Climat
KO:006660
|
0.009x |
Annual Cash Flow Conversion Efficiency for DHG Pharmaceutical JSC (2019–2025)
The table below shows the annual cash flow conversion efficiency of DHG Pharmaceutical JSC from 2019 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₫4.18 Trillion | ₫1.22 Trillion | 0.293x | -9.05% |
| 2024-12-31 | ₫4.09 Trillion | ₫1.32 Trillion | 0.322x | +457.94% |
| 2023-12-31 | ₫4.85 Trillion | ₫279.88 Billion | 0.058x | -72.54% |
| 2022-12-31 | ₫4.29 Trillion | ₫901.28 Billion | 0.210x | +76.07% |
| 2021-12-31 | ₫3.79 Trillion | ₫452.44 Billion | 0.119x | -48.49% |
| 2020-12-31 | ₫3.57 Trillion | ₫826.17 Billion | 0.232x | -6.70% |
| 2019-12-31 | ₫3.38 Trillion | ₫838.24 Billion | 0.248x | -- |